Amgen announces an expansion plan in Rhode Island, with a new $160-million next-generation biomanufacturing plant. The facility will be built on the current Amgen Rhode Island 75-acre campus in West Greenwich and will manufacture products for the US as well as global markets. Incorporating multiple technologies into a single facility, the plant will be built in half the construction time with approximately half of the operating cost required of a traditional plant. Next-generation biomanufacturing plants require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water, energy, and lower levels of carbon emissions.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.